Tufts Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Tufts Medical Center sits in the top decile of US sponsors by registered trial count (#171 of 15,742 sponsors by registered trial count).
Tufts Medical Center: 169 sponsored US clinical trials, 18 recruiting.
Tufts Medical Center sponsors 169 registered US clinical trials on ClinicalTrials.gov, 18 of them currently recruiting, and 111 completed. 27 of these trials are in Phase 3-4 (later-stage) and 44 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 5 trials.
Top-decile sponsor footprint
Tufts Medical Center ranks in the top decile of sponsors by registered trial count (#171 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
111 of 139 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
169 total, page 2 of 4
Relationship Between Strain and Stroke Volume in Cardiac Surgery
NCT04694378
Niclosamide for Mild to Moderate COVID-19
NCT04399356
Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED)
NCT04527887
Mind-body Therapy (Remotely Delivered) for Knee Osteoarthritis
NCT04678999
Screening to Improve Survival in AL Amyloidosis
NCT04615572
Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab
NCT04306965
A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).
NCT04425538
Inhaled Nitric Oxide for Preventing Progression in COVID-19
NCT04388683
Effects of High Flow Nasal Cannula on Sputum Clearance in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT04217746
Cervical Stiffness Measurement in Cervical Insufficiency
NCT04158401
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134
Defining the 'Sniffing Position" in Infants and Toddlers - A Pilot Study
NCT04410289
H+ Mobilization With Dialysate Bicarbonate Variation
NCT04020757
Prepared Meals to Prime and Perpetuate Reduced Dietary Sodium Intake in Hemodialysis
NCT03990311
Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial
NCT03678675
Body Composition Ultrasound for Patients With Heart Failure
NCT03948776
Genomic Medicine for Ill Neonates and Infants (The GEMINI Study)
NCT03890679
Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept
NCT03396861
Audio-Visual Relaxation Technology for Pediatric Amplified Musculoskeletal Pain Syndrome
NCT03762213
Intranasal Neurostimulation in Ameliorating Symptoms of Neuropathic Corneal Pain
NCT03674892
Durapore vs. Hy-Tape to Secure The Endotracheal Tube
NCT03633877
Tegaderm vs. EyeGard for Eye Protection
NCT03549429
Music vs. No Music During Cesarean Delivery on Patient Satisfaction
NCT03412019
Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer
NCT03737370
Intrathecal Chloroprocaine vs. Bupivacaine for Cervical Cerclage
NCT03305575
Renal AL Amyloid Involvement and NEOD001
NCT03168906
Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study
NCT03886454
Dialysate Sodium Lowering Trial
NCT03144817
Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)
NCT03159936
Lifestyle Intervention in Preparation for Pregnancy (LIPP)
NCT03146156
Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids
NCT02977286
Supporting Mothers of Preterm Infants
NCT03013660
Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
NCT03000660
Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa
NCT03099980
Preoperative Acetaminophen and Carbohydrate Loading
NCT03131713
Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
NCT02561000
Do Single Use Negative Pressure Dressings Reduce Wound Complications in Obese Women After Cesarean Delivery
NCT02799667
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early
NCT02741999
Topical Ruxolitinib for the Treatment of Vitiligo
NCT02809976
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis
NCT02555969
Effectiveness of the Aeroneb in Acute Severe Asthma
NCT03029156
Pilot Study of Physiological Effect of High-Flow Nasal Cannula on Respiratory Pattern and Work of Breathing
NCT02514798
Tai Chi Intervention and Brain Imaging Study Among Fibromyalgia Patients and Healthy Controls
NCT02407665
Evaluation of Non-Invasive Respiratory Volume Monitor
NCT03039881
Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure
NCT03001674
A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure
NCT02084992
Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease
NCT02225860
Treatment of Dyspnea in Do-not-intubate Patients
NCT02114944
The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED
NCT02120079
Ocular Surface Immune Response in Dry Eye Disease
NCT02042820
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 18 |
| Phase 2 | 26 |
| Phase 3 | 11 |
| Phase 4 | 16 |
What is open in the Tufts Medical Center pipeline
18 recruiting of 169 indexed (11% open); 111 completed (66%).
Phase mix: 27 late (III/IV) vs 44 early (I/II) (early-phase heavy).
Top condition: Heart Failure (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Tufts Medical Center: open-pipeline peers nationwide
Peers matched on 169 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Tufts Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 169 trials (± recruiting share)
- Astellas Pharma Global Development · 168 trials · 11% recruiting
- Bausch Health Americas · 168 trials · 4% recruiting
- Seattle Children's Hospital · 168 trials · 17% recruiting
- Sumitomo Pharma America · 168 trials · 4% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Hartford Hospital · 11% recruiting · 75 trials
- UConn Health · 11% recruiting · 178 trials
- CAMC Health System · 11% recruiting · 28 trials
- Bastyr University · 11% recruiting · 19 trials
Related
What to do with this Tufts Medical Center page
169 registered trials is a research-attention snapshot, not an endorsement of Tufts Medical Center or any single study.
- 18 of Tufts Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Tufts Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Tufts Medical Center pipeline card: 169 registered trials from official public datasets.Report a data error.